Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fatty liver
(i.e., hepatic lipidosis) is a major metabolic disorder of many dairy cows in early lactation and is associated with decreased health status and reproductive performance. In severe cases, milk production and feed intake are decreased. Therefore, a practical preventative or an efficacious treatment of
fatty liver
could save millions of dollars yearly in treatment, replacement, and production losses for dairy farmers.
Fatty liver
develops when the hepatic uptake of lipids exceeds the oxidation and secretion of lipids by the liver, which usually is preceded by high concentrations of plasma NEFA mobilized from adipose tissue. Excess lipids are stored as triacylglycerol in the liver and are associated with decreased metabolic functions of the liver. Liver can be categorized into normal liver or mild, moderate, or severe
fatty liver
; the latter can be subdivided further into nonencephalopathic severe
fatty liver
and hepatic encephalopathy. Insufficient or unbalanced dietary intake, obesity, and elevated estrogen concentrations are involved in the etiology of
fatty liver
, which is associated with greater incidence of
dystocia
, diseases, infections, and inflammations. Because even mild
fatty liver
is associated with decreased health status and reproductive performance of dairy cows, prevention of
fatty liver
by supplying cows with sufficient nutrients and a clean and health-promoting environment in the peripartal period would reduce production losses of cows more than would any treatment of
fatty liver
. This, however, might not be enough for cows that are obese or do not eat well, had calving difficulties or twins, have metabolic or infectious diseases, or are in severe negative energy balance because of high milk production immediately after calving. Potential and commonly used preventatives, as well as treatments, are discussed in the review. Currently, detection of
fatty liver
is possible only by minor surgery. Ultrasonic techniques offer a potential tool to noninvasively detect
fatty liver
. Future gene-array and proteomic studies may provide means to detect early molecular events in the etiology of
fatty liver
plus their connection with immune function and reproductive performance so that more effective treatments and preventatives of
fatty liver
can be developed. Such advances hopefully will make
fatty liver
a problem of the past.
...
PMID:Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows. 1537 89
Common health problems observed during peripartum include milk fever, mastitis,
fatty liver
disease, ketosis,
dystocia
, retained placenta, metritis, hypomagnesaemia and abomasal displacements. The increased incidence of health problems observed during the periparturient period can be partly attributed to suboptimal immune responses. Factors contributing to decreased periparturient immunity include the act of parturition itself, impaired leukocytic activity, effects of colostrogenesis and lactogenesis, and associated hypocalcemia and negative energy balance. Nutritional and other management strategies represent a relevant short-term strategy aimed at improving the health and welfare of the transitioning cow. Additionally, it is important to consider improving the health of dairy herds through the genetic selection of animals with enhanced robustness by identifying those with superior disease resistance or resilience in the face of infection. As a consequence these animals are better able to cope with the production and environmental stresses. These may provide long-term selection strategies for improving the health and welfare of the transitioning cow particularly when combined with sound management practices, allowing dairy cattle to reach their full genetic potential.
...
PMID:Periparturient immunosuppression and strategies to improve dairy cow health during the periparturient period. 2766 64